Create Account | Sign In: Author or Forum

Search Symptoms

Category: Family Medicine | Internal Medicine | Pathology | Pharmacy | AIDS | Institutional

Back to Journal Articles

PrEP HIV Prevention Pills to Be Free for Insured Americans

Last Updated: July 21, 2021.

WEDNESDAY, July 21, 2021 (HealthDay News) -- Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis (PrEP) drugs Truvada and Descovy, all clinic visits, and lab tests, NBC News reported.

The guidance, issued this week by the U.S. Centers for Medicare & Medicaid Services, along with the Department of Labor and the Department of the Treasury, means that a prescription for Truvada and Descovy should now be free for almost all insured people. Insurers, which were required to stop charging out-of-pocket fees for PrEP as of Jan. 1, have 60 days to comply with the latest rules, NBC News reported.

The U.S. Preventive Services Task Force granted PrEP an "A" rating in 2019. Under the Affordable Care Act, that means the preventive treatment must be covered by almost all insurers at no cost to the patient.

HIV prevention advocates said Tuesday the new guidance was a game changer. "While we need state Medicaid authorities and departments of insurance to follow through on implementation, this memo from the federal government literally made me jump for joy," Jim Pickett, senior director of prevention advocacy and gay men's health at AIDS Foundation Chicago, told NBC News. "This has the potential to wipe out many of the access obstacles we face with PrEP provision. I look forward to radical improvements in PrEP access, particularly for the communities who are most vulnerable to HIV."

NBC News Article


Previous: In a First for the Continent, Pfizer COVID-19 Vaccine Will Be Produced in South Africa Next: No Increase in Risk With Dapagliflozin in Patients With Stage 4 CKD

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: